These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 12644214

  • 1. DD23 Biomarker: a prospective clinical assessment in routine urinary cytology specimens from patients being monitored for TCC.
    Sawczuk IS, Pickens CL, Vasa UR, Ralph DA, Norris KA, Miller MC, Ng AY, Grossman HB, Veltri RW.
    Urol Oncol; 2002; 7(5):185-90. PubMed ID: 12644214
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.
    Gilbert SM, Veltri RW, Sawczuk A, Shabsigh A, Knowles DR, Bright S, O'Dowd GJ, Olsson CA, Benson MC, Sawczuk IS.
    Urology; 2003 Mar; 61(3):539-43. PubMed ID: 12639642
    [Abstract] [Full Text] [Related]

  • 3. Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?
    Wiener HG, Mian C, Haitel A, Pycha A, Schatzl G, Marberger M.
    J Urol; 1998 Jun; 159(6):1876-80. PubMed ID: 9598479
    [Abstract] [Full Text] [Related]

  • 4. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S, Swellam M, Sadek M, Mourad MS, El Ahmady O, Khalifa A.
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [Abstract] [Full Text] [Related]

  • 5. The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies.
    Raitanen MP, FinnBladder Group.
    World J Urol; 2008 Feb; 26(1):45-50. PubMed ID: 18180926
    [Abstract] [Full Text] [Related]

  • 6. Comparative study of NMP-22, telomerase, and BTA in the detection of bladder cancer.
    Abd El Gawad IA, Moussa HS, Nasr MI, El Gemae EH, Masooud AM, Ibrahim IK, El Hifnawy NM.
    J Egypt Natl Canc Inst; 2005 Sep; 17(3):193-202. PubMed ID: 16799657
    [Abstract] [Full Text] [Related]

  • 7. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
    Friedrich MG, Hellstern A, Hautmann SH, Noldus I, Huland H.
    Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
    [Abstract] [Full Text] [Related]

  • 8. Human complement factor H related protein test for monitoring bladder cancer.
    Raitanen MP, Marttila T, Nurmi M, Ala-Opas M, Nieminen P, Aine R, Tammela TL, Finnbladder Group.
    J Urol; 2001 Feb; 165(2):374-7. PubMed ID: 11176376
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer.
    Leyh H, Marberger M, Conort P, Sternberg C, Pansadoro V, Pagano F, Bassi P, Boccon-Gibod L, Ravery V, Treiber U, Ishak L.
    Eur Urol; 1999 Jan; 35(1):52-6. PubMed ID: 9933795
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the nuclear matrix protein 22 with voided urine cytology and BTA stat test in the diagnosis of transitional cell carcinoma of the bladder.
    Sözen S, Biri H, Sinik Z, Küpeli B, Alkibay T, Bozkirli I.
    Eur Urol; 1999 Sep; 36(3):225-9. PubMed ID: 10450007
    [Abstract] [Full Text] [Related]

  • 11. Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study.
    Pichler R, Tulchiner G, Fritz J, Schaefer G, Horninger W, Heidegger I.
    Int J Med Sci; 2017 Sep; 14(9):811-819. PubMed ID: 28824318
    [Abstract] [Full Text] [Related]

  • 12. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
    Pfister C, Chautard D, Devonec M, Perrin P, Chopin D, Rischmann P, Bouchot O, Beurton D, Coulange C, Rambeaud JJ.
    J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
    [Abstract] [Full Text] [Related]

  • 13. Role of NMP22 Bladder Check Test in early detection of bladder cancer with recurrence.
    Kundal VK, Pandith AA, Hamid A, Shah A, Kundal R, Wani SM.
    Asian Pac J Cancer Prev; 2010 Mar; 11(5):1279-82. PubMed ID: 21198277
    [Abstract] [Full Text] [Related]

  • 14. Qualitative and quantitative detection of urinary human complement factor H-related protein (BTA stat and BTA TRAK) and fragments of cytokeratins 8, 18 (UBC rapid and UBC IRMA) as markers for transitional cell carcinoma of the bladder.
    Babjuk M, Kostírová M, Mudra K, Pecher S, Smolová H, Pecen L, Ibrahim Z, Dvorácek J, Jarolím L, Novák J, Zima T.
    Eur Urol; 2002 Jan; 41(1):34-9. PubMed ID: 11999463
    [Abstract] [Full Text] [Related]

  • 15. BTA quantitative assay and NMP22 testing compared with urine cytology in the detection of transitional cell carcinoma of the bladder.
    Casetta G, Gontero P, Zitella A, Pelucelli G, Formiconi A, Priolo G, Martinasso G, Mengozzi G, Aimo G, Viberti L, Tizzani A.
    Urol Int; 2000 Jan; 65(2):100-5. PubMed ID: 11025432
    [Abstract] [Full Text] [Related]

  • 16. Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells.
    Bonner RB, Hemstreet GP, Fradet Y, Rao JY, Min KW, Hurst RE.
    Cancer; 1993 Oct 15; 72(8):2461-9. PubMed ID: 8402463
    [Abstract] [Full Text] [Related]

  • 17. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM, García Rodríguez J, Escaf Barmadah S, Raigoso P, Rodríguez Martínez JJ, Allende MT, Casasola Chamorro J, Rodríguez Faba O, Martín Benito JL, Regadera Sejas FJ.
    Arch Esp Urol; 2002 Oct 15; 55(1):41-9. PubMed ID: 11957750
    [Abstract] [Full Text] [Related]

  • 18. A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study.
    Davis N, Shtabsky A, Lew S, Rona R, Leibovitch I, Nativ O, Cohen M, Mor Y, Lindner U, Glickman Y, Matzkin H, Tsivian A, Gofrit O, Yossepovitch O.
    Eur Urol Focus; 2018 Apr 15; 4(3):388-394. PubMed ID: 28753799
    [Abstract] [Full Text] [Related]

  • 19. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P, Neulander E, Zirkin H, Yusim I, Douvdevani A, Mermershtain W, Kaneti J, Manor E.
    Urology; 2004 Feb 15; 63(2):398-401. PubMed ID: 14972510
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the NMP22 test and comparison with voided urine cytology in the detection of bladder cancer.
    Lee KH.
    Yonsei Med J; 2001 Feb 15; 42(1):14-8. PubMed ID: 11293494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.